Drugs: E
Most viewed starting with E
Estradiol
The principal endogenous human estrogen, which "acts through binding to nuclear receptors in estrogen-responsive tissues," modulating the pituitary secretion of gonadotropins (LH/FSH) through negative feedback and exerting effects on bone, the reproductive tract, and other estrogen-responsive tissues.
1061 identified pills
Escitalopram
Pharmacologic Class: Selective serotonin reuptake inhibitor (SSRI)
291 identified pills
Enalapril
"Angiotensin-converting enzyme (ACE) inhibitor" - after oral administration, enalapril maleate is bioactivated to enalaprilat, which "inhibits angiotensin-converting enzyme (ACE)," suppressing the "renin-angiotensin-aldosterone system" and decreasing vasopressor activity and aldosterone secretion.
253 identified pills
Esomeprazole
A "proton pump inhibitor (PPI)" that "suppress[es] gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system" in the gastric parietal cell, blocking the final step of acid production in a dose-dependent manner.
231 identified pills
Etodolac
A "member of the pyranocarboxylic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs)." Its mode of action, like other NSAIDs, "may be related to prostaglandin synthetase inhibition."
185 identified pills
Eszopiclone
A "nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class." Its effect is "believed to result from its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors."
170 identified pills
All drugs starting with E
EDOXABAN TOSYLATE
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
0 identified pills
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
0 identified pills
EFLORNITHINE HYDROCHLORIDE
Antiprotozoal [EPC]; Decarboxylase Inhibitor [EPC]; Decarboxylase Inhibitors [MoA]
0 identified pills
ELBASVIR and GRAZOPREVIR
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HCV NS3/4A Protease Inhibitors [MoA]; Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]; Hepatitis C Virus NS5A Inhibitor [EPC]
0 identified pills
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
0 identified pills
ENALAPRIL MALEATE
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Decreased Blood Pressure [PE]
0 identified pills
ENTECAVIR ANHYDROUS
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
0 identified pills
ENTRECTINIB
0 identified pills
EPLERENONE
Aldosterone Antagonist [EPC]; Aldosterone Antagonists [MoA]
0 identified pills
ERGOCALCIFEROL
Provitamin D2 Compound [EPC]
0 identified pills
ERLOTINIB
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
0 identified pills
ERYTHROMYCIN
Macrolide [EPC]; Macrolide Antimicrobial [EPC]
0 identified pills
ERYTHROMYCIN ETHYLSUCCINATE
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
0 identified pills
ESOMEPRAZOLE MAGNESIUM
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
0 identified pills
ESTERIFIED ESTROGENS, METHYLTESTOSTERONE
Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
0 identified pills
ESTRADIOL AND NORETHINDRONE ACETATE
Estrogen [EPC]; Estrogen Receptor Agonists [MoA]
0 identified pills
ETHACRYNIC ACID
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
0 identified pills
ETHOSUXIMIDE
Anti-epileptic Agent [EPC]
0 identified pills
ETOPOSIDE
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
0 identified pills
EVEROLIMUS
Kinase Inhibitor [EPC]; mTOR Inhibitor Immunosuppressant [EPC]; Protein Kinase Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; mTOR Inhibitors [MoA]
0 identified pills
EXTRA STRENGHT HEADACHE RELIEF- acetaminophen, aspirin, caffeine tablet
Anti-Inflammatory Agents; Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]
0 identified pills
EZETIMIBE
Dietary Cholesterol Absorption Inhibitor [EPC]
0 identified pills
Efavirenz
Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
0 identified pills
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
0 identified pills
Elacestrant
Breast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
0 identified pills
Elagolix
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
0 identified pills
Eletriptan HBR
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
0 identified pills
Eletriptan Hydrobromide
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
0 identified pills
Elexacaftor, Tezacaftor, and Ivacaftor
0 identified pills
Eltrombopag
Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Thrombopoietin Receptor Agonist [EPC]; Thrombopoietin Receptor Agonists [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A3 Inhibitors [MoA]; UGT1A4 Inhibitors [MoA]; UGT1A6 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]; UGT2B15 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]
0 identified pills
Eltrombopag olamine
Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Thrombopoietin Receptor Agonist [EPC]; Thrombopoietin Receptor Agonists [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A3 Inhibitors [MoA]; UGT1A4 Inhibitors [MoA]; UGT1A6 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]; UGT2B15 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]
0 identified pills
Eluxadoline
Opioid mu-Receptor Agonists [MoA]; mu-Opioid Receptor Agonist [EPC]
0 identified pills
Empagliflozin
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
0 identified pills
Emtricitabine
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
0 identified pills
Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
0 identified pills
Emtricitabine/TDF
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
0 identified pills
Enalapril
"Angiotensin-converting enzyme (ACE) inhibitor" - after oral administration, enalapril maleate is bioactivated to enalaprilat, which "inhibits angiotensin-converting enzyme (ACE)," suppressing the "renin-angiotensin-aldosterone system" and decreasing vasopressor activity and aldosterone secretion.
253 identified pills
Encorafenib
0 identified pills
Ensitrelvir
0 identified pills
Entacapone
Catechol O-Methyltransferase Inhibitors [MoA]; Catechol-O-Methyltransferase Inhibitor [EPC]
0 identified pills
Entecavir
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
0 identified pills
Enzalutamide
Androgen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]
0 identified pills
Ephedrine Hydrochloride
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
0 identified pills
Ephedrine Sulfate
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
0 identified pills
Erdafitinib
Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Fibroblast Growth Factor Receptor Inhibitors [MoA]; Kinase Inhibitor [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
0 identified pills
Ergocalciferol (Vitamin D2)
Ergocalciferols [CS]; Provitamin D2 Compound [EPC]
0 identified pills
Ergocalciferol Capsules,
Ergocalciferols [CS]; Provitamin D2 Compound [EPC]
0 identified pills
Ergotamine Tartrate
Ergotamine Derivative [EPC]; Ergotamines [CS]
0 identified pills